Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients
- 1 July 1999
- journal article
- Published by Elsevier in Kidney International
- Vol. 56 (1) , 289-298
- https://doi.org/10.1046/j.1523-1755.1999.00521.x
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidationThe Lancet, 1997
- Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.Journal of Clinical Investigation, 1995
- Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonaseAtherosclerosis, 1993
- Role of oxidized low density lipoprotein in atherogenesis.Journal of Clinical Investigation, 1991
- Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein.Journal of Clinical Investigation, 1991
- Long-term complications of renal transplantationKidney International, 1990
- High-density lipoprotein inhibits the oxidative modification of low-density lipoproteinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Protective effect of lipoproteins containing apoprotein A‐I on Cu2+ ‐ catalyzed oxidation of human low density lipoproteinFEBS Letters, 1989
- Risk factors for accelerated atherosclerosis in renal transplant recipientsThe American Journal of Medicine, 1988
- Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosisAmerican Heart Journal, 1987